We are live on ! Find out more
JHIU

Janus Henderson Investors US Portfolio holdings

AUM $122B
1-Year Est. Return 18.26%
This Fund
S&P 500
This Quarter Est. Return
+4.99%
1 Year Est. Return
+18.26%
3 Year Est. Return
+41.86%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$109B
AUM Growth
+$1.63B
Cap. Flow
-$2.98B
Cap. Flow %
-2.73%
Top 10 Hldgs %
13.68%
Holding
1,141
New
86
Increased
455
Reduced
516
Closed
52

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$245M
2
PCYC
PHARMACYCLICS INC
PCYC
+$225M
3
MSFT icon
Microsoft
MSFT
+$217M
4
ZBH icon
Zimmer Biomet
ZBH
+$207M
5
LVS icon
Las Vegas Sands
LVS
+$173M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$420M
2
ORCL icon
Oracle
ORCL
+$389M
3
TDC icon
Teradata
TDC
+$305M
4
CP icon
Canadian Pacific Kansas City
CP
+$249M
5
CELG
Celgene Corp
CELG
+$245M

Sector Composition

Rank Sector Weight
1 Healthcare 16.92%
2 Technology 14.89%
3 Industrials 12.48%
4 Financials 11.62%
5 Consumer Discretionary 10.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDVN
76
DELISTED
MEDIVATION, INC.
MDVN
$347M 0.32%
8,994,146
+116,232
+1% +$3.92M
LMT icon
77
Lockheed Martin
LMT
$139B
$345M 0.32%
2,147,576
+474,700
+28% +$77.2M
CI icon
78
Cigna
CI
$73.6B
$334M 0.31%
3,628,441
-228,000
-6% -$19.6M
KR icon
79
Kroger
KR
$34.6B
$331M 0.3%
13,396,656
-2,565,686
-16% -$59.8M
ABT icon
80
Abbott
ABT
$188B
$329M 0.3%
8,057,291
-2,478,897
-24% -$97.3M
TMO icon
81
Thermo Fisher Scientific
TMO
$222B
$329M 0.3%
2,788,477
+296,466
+12% +$34.9M
MRK icon
82
Merck
MRK
$323B
$329M 0.3%
5,952,336
+749,099
+14% +$40.9M
ATHN
83
DELISTED
Athenahealth, Inc.
ATHN
$325M 0.3%
2,596,912
+169,683
+7% +$21.9M
SSNC icon
84
SS&C Technologies
SSNC
$18.7B
$324M 0.3%
14,670,002
-162,604
-1% -$3.36M
WFM
85
DELISTED
Whole Foods Market Inc
WFM
$320M 0.29%
8,296,720
-480,646
-5% -$20.9M
YHOO
86
DELISTED
Yahoo Inc
YHOO
$319M 0.29%
9,096,595
-704,164
-7% -$24.6M
ECL icon
87
Ecolab
ECL
$79.7B
$309M 0.28%
2,772,702
-4,100
-0.1% -$439K
DOX icon
88
Amdocs
DOX
$6.22B
$302M 0.28%
6,510,312
-192,204
-3% -$9.05M
VTRS icon
89
Viatris
VTRS
$18.7B
$301M 0.28%
5,828,946
-12,009
-0.2% -$590K
AZO icon
90
AutoZone
AZO
$50.1B
$298M 0.27%
554,895
+159,676
+40% +$84.5M
BHC icon
91
Bausch Health
BHC
$2.37B
$295M 0.27%
2,347,582
+455,380
+24% +$58.1M
CCI icon
92
Crown Castle
CCI
$31.3B
$294M 0.27%
3,968,959
-231,196
-6% -$17.3M
JOE icon
93
St. Joe Company
JOE
$3.77B
$293M 0.27%
11,537,000
+42,626
+0.4% +$915K
OCR
94
DELISTED
OMNICARE INC
OCR
$290M 0.27%
4,359,831
+2,969
+0.1% +$184K
PCYC
95
DELISTED
PHARMACYCLICS INC
PCYC
$289M 0.26%
3,221,572
+2,394,937
+290% +$225M
VZ icon
96
Verizon
VZ
$195B
$287M 0.26%
5,873,701
-462,767
-7% -$22.4M
C icon
97
Citigroup
C
$227B
$286M 0.26%
6,069,766
-2,820,259
-32% -$134M
PBR icon
98
Petrobras
PBR
$118B
$281M 0.26%
19,224,676
-712,347
-4% -$10.4M
PSX icon
99
Phillips 66
PSX
$86B
$281M 0.26%
3,491,312
+795,411
+30% +$65.5M
ZTS icon
100
Zoetis
ZTS
$30.9B
$277M 0.25%
8,637,264
-1,813,313
-17% -$55.6M
2 3
4
5 6

Similar funds

TCT
TIAA CREF Trust St Louis, Missouri $13.8B AUM 10.67% 1-Year Est. Return
EAM
Edge Asset Management Seattle, Washington $13.2B AUM 19.52% 1-Year Est. Return
PIM
Perkins Investment Management Chicago, Illinois $8.09B AUM 25.47% 1-Year Est. Return
EPCM
Eton Park Capital Management New York $2.28B AUM 33.59% 1-Year Est. Return
ICM
IronBridge Capital Management Oakbrook Terrace, Illinois $1.65B AUM 18.98% 1-Year Est. Return
AIU
Algebris Investments (UK) London, United Kingdom $926M AUM 4.74% 1-Year Est. Return
LAM
Lebenthal Asset Management New York $807M AUM 17.92% 1-Year Est. Return
LT
LJ Trust Reno, Nevada $746M AUM 12.18% 1-Year Est. Return

Janus Henderson Investors US's Q2 2014 Portfolio in Review

As of Q2 2014, Janus Henderson Investors US held 1,141 positions worth $109B, up 1.5% from $107B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Janus Henderson Investors US's Q2 2014 filing shows 86 new, 455 increased, 516 reduced and 52 closed positions. Its largest new stake was Lands' End: 3,215,073 shares worth $108M. The largest sale was Gilead Sciences, an estimated $420M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.

  • Janus Henderson Investors US's largest Q2 2014 buy was Lands' End: 3,215,073 shares worth $108M.
  • Janus Henderson Investors US added most to Meta Platforms (Facebook) in Q2 2014, an estimated $245M increase.
  • Janus Henderson Investors US's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $420M.
  • Janus Henderson Investors US fully exited CIT Group Inc. in Q2 2014, selling an estimated $124M.
  • Janus Henderson Investors US's ten largest holdings make up 14% of its $109B portfolio in Q2 2014.
  • Janus Henderson Investors US opened 86 new positions and closed 52 in Q2 2014.
  • Janus Henderson Investors US's portfolio value rose 1.5% quarter-over-quarter to $109B.

Based on Janus Henderson Investors US's 13F filing for Q2 2014, filed 14 Aug 2014.